38519492|t|FBXO22 promotes glioblastoma malignant progression by mediating VHL ubiquitination and degradation.
38519492|a|Glioblastoma (GBM) is the most common malignant primary brain tumor. Despite comprehensive treatment with traditional surgery, radiotherapy, and chemotherapy, the median survival rate is <14.6% and the 5-year survival rate is only 5%. FBXO22, a substrate receptor of the SCF ubiquitin ligases, has been reported to play a promoting role in melanoma, liver cancer, cervical cancer, and other cancers. However, the function of FBXO22 in GBM has not been reported. In the present study, we demonstrate that FBXO22 is highly expressed in glioma and is positively correlated with worse pathological features and shorter survival of GBM patients. We revealed that FBXO22 promotes GBM cell proliferation, angiogenesis, migration, and tumorigenesis in vitro and in vivo. In terms of mechanism, we reveal that FBXO22 decreases VHL expression by directly mediating VHL ubiquitination degradation, which ultimately increases HIF-1alpha and VEGFA expression. In addition, our data confirm that there are positive correlations among FBXO22, HIF-1alpha, and VEGFA expression, and there is a negative correlation between FBXO22 and VHL protein expression in glioma patients. Our study strongly indicates that FBXO22 is a promising diagnostic marker and therapeutic target for glioma patients.
38519492	0	6	FBXO22	Gene	26263
38519492	16	28	glioblastoma	Disease	MESH:D005909
38519492	64	67	VHL	Gene	7428
38519492	100	112	Glioblastoma	Disease	MESH:D005909
38519492	114	117	GBM	Disease	MESH:D005909
38519492	148	167	primary brain tumor	Disease	MESH:D001932
38519492	335	341	FBXO22	Gene	26263
38519492	440	448	melanoma	Disease	MESH:D008545
38519492	450	462	liver cancer	Disease	MESH:D006528
38519492	464	479	cervical cancer	Disease	MESH:D002583
38519492	491	498	cancers	Disease	MESH:D009369
38519492	525	531	FBXO22	Gene	26263
38519492	535	538	GBM	Disease	MESH:D005909
38519492	604	610	FBXO22	Gene	26263
38519492	634	640	glioma	Disease	MESH:D005910
38519492	727	730	GBM	Disease	MESH:D005909
38519492	731	739	patients	Species	9606
38519492	758	764	FBXO22	Gene	26263
38519492	774	777	GBM	Disease	MESH:D005909
38519492	827	840	tumorigenesis	Disease	MESH:D063646
38519492	901	907	FBXO22	Gene	26263
38519492	918	921	VHL	Gene	7428
38519492	955	958	VHL	Gene	7428
38519492	1014	1024	HIF-1alpha	Gene	3091
38519492	1029	1034	VEGFA	Gene	7422
38519492	1120	1126	FBXO22	Gene	26263
38519492	1128	1138	HIF-1alpha	Gene	3091
38519492	1144	1149	VEGFA	Gene	7422
38519492	1206	1212	FBXO22	Gene	26263
38519492	1217	1220	VHL	Gene	7428
38519492	1243	1249	glioma	Disease	MESH:D005910
38519492	1250	1258	patients	Species	9606
38519492	1294	1300	FBXO22	Gene	26263
38519492	1361	1367	glioma	Disease	MESH:D005910
38519492	1368	1376	patients	Species	9606
38519492	Positive_Correlation	3091	7428
38519492	Positive_Correlation	26263	7422
38519492	Association	MESH:D002583	26263
38519492	Association	MESH:D009369	26263
38519492	Association	MESH:D008545	26263
38519492	Association	MESH:D006528	26263
38519492	Positive_Correlation	7422	7428
38519492	Positive_Correlation	26263	3091
38519492	Association	MESH:D005910	7428
38519492	Association	MESH:D005909	7428
38519492	Association	MESH:D005909	26263
38519492	Positive_Correlation	MESH:D063646	26263
38519492	Association	MESH:D005910	26263
38519492	Negative_Correlation	26263	7428

